Project Details
Description
A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naive, Male Pediatric Patients Without Severe Symptoms (FIELD)
Status | Finished |
---|---|
Effective start/end date | 1/1/13 → 12/31/17 |
Funding
- GENZYME CORPORATION